Simply provide us with your current strength and dosage in the history section of the questionnaire, and well align with your existing injection schedule
By October 2025, Reuters reported that Mounjaro had become Indias top-selling drug by value, generating about 1 billion in sales that month
This helps in preserving their quality until its time to use them
A supportive medical weight loss program acknowledges these challenges
In July 2025, we announced new data from Week 156 of our Phase 3 PaTHway Trial, confirming that long-term treatment with TransCon PTH (palopegteriparatide) continued to provide a durable response in adults with hypoparathyroidism regardless of its cause (post-surgical, autoimmune, genetic, or idiopathic), including improvements in biochemistries, kidney function, and quality of life